Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 21,224 | 19,556 | 15,961 | 23,007 | 16,520 |
| Operating Income | -21,224 | -19,556 | -15,961 | -23,007 | -16,520 |
| Other Income | -129 | -145 | -290 | -174 | -147 |
| Pre-tax Income | -21,353 | -19,701 | -16,251 | -23,181 | -16,667 |
| Net Income Continuous | -21,353 | -19,701 | -16,251 | -23,181 | -16,667 |
| Net Income | $-21,353 | $-19,701 | $-16,251 | $-23,181 | $-16,667 |
| EPS Basic Total Ops | -10.92 | 878.99 | -297.90 | -440.90 | -329.55 |
| EPS Basic Continuous Ops | -10.93 | 879.02 | -297.96 | -440.84 | -329.58 |
| EPS Diluted Total Ops | -10.92 | 878.99 | -297.90 | -440.90 | -329.55 |
| EPS Diluted Continuous Ops | -10.93 | 879.02 | -297.96 | -440.84 | -329.58 |
| EBITDA(a) | $-20,784 | $-19,162 | $-15,579 | $-22,634 | $-16,170 |